It has been shown that DENV-2 induced IL-6, IFN-γ, and IL-10, and quercetin, naringin, catechin, and fisetin can change signaling pathways in the innate response to reduce neurological disorders being hopeful candidates for therapy of neurological disorders (Igbe et al., 2017). This evidence concerns the gene IFNG and nervous system disorder.